Teladoc Health (STU:4LL) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4LL Teladoc Health Inc STU:4LL
59 GF Score
Price €5.59
GF Value €7.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Teladoc Health 5-Year EBITDA Growth Rate?

Teladoc Health STU:4LL +2.57% 59 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates STU:4LL with a GF Score™ of 59/100 and a GF Value™ of €7.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Teladoc Health's EBITDA per Share for the three months ended in Jun. 2026 was €0.29.

During the past 12 months, Teladoc Health's average EBITDA Per Share Growth Rate was 31.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Teladoc Health was 40.60% per year. The lowest was -453.30% per year. And the median was -71.05% per year.

Teladoc Health  (STU:4LL) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Teladoc Health 5-Year EBITDA Growth Rate Related Terms

STU:4LL vs GDRX, CERT, OMDA: 5-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, Teladoc Health's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teladoc Health 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Teladoc Health's 5-Year EBITDA Growth Rate falls into.


STU:4LL
59GF Score
Teladoc Health Inc STU:4LL
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teladoc Health 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Teladoc Health (STU:4LL) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Teladoc Health and its competitors.
Is Teladoc Health's 5-Year EBITDA Growth Rate too high?
Teladoc Health's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Teladoc Health has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's 5-Year EBITDA Growth Rate compare to GDRX and CERT?
Teladoc Health's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Teladoc Health and its competitors. Teladoc Health's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.07, compared to a current price of €5.59 — trading 20.9% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Teladoc Health's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teladoc Health (STU:4LL) Overvalued in 2026?

Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued. The current stock price of €5.59 is trading 20.9% below its estimated GF Value™ of €7.07. GuruFocus considers Teladoc Health to be Modestly Undervalued.

Key valuation signals for STU:4LL:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: €7.07 vs. price of €5.59 (20.9% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teladoc Health Business Description

Address 155 East 44th Street, Suite 1700, New York, NY, USA, 10017
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
59GF Score

Get the complete analysis for STU:4LL

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.59
Price
€7.07
GF Value